BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27890176)

  • 1. The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management.
    Molloy ES; Calabrese CM; Calabrese LH
    Rheum Dis Clin North Am; 2017 Feb; 43(1):95-109. PubMed ID: 27890176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
    Molloy ES; Calabrese LH
    Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progressive multifocal leukoencephalopathy and rheumatic disease].
    Kneitz C; Wiendl H
    Z Rheumatol; 2008 Jul; 67(4):290, 292-4. PubMed ID: 18483740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases.
    Molloy ES; Calabrese LH
    Arthritis Rheum; 2009 Dec; 60(12):3761-5. PubMed ID: 19950261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
    Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
    J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies.
    Calabrese LH; Molloy ES
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii64-5. PubMed ID: 19022817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive multifocal leukoencephalopathy restricted to the posterior fossa in a patient with systemic lupus erythematosus.
    Gonçalves FG; Lamb L; Del Carpio-O'Donovan R
    Braz J Infect Dis; 2011; 15(6):609-12. PubMed ID: 22218525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies.
    Molloy ES; Calabrese LH
    Arthritis Rheum; 2012 Sep; 64(9):3043-51. PubMed ID: 22422012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy in autoimmune diseases.
    Palazzo E; Yahia SA
    Joint Bone Spine; 2012 Jul; 79(4):351-5. PubMed ID: 22281228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PML and rheumatology: the contribution of disease and drugs.
    Molloy ES
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S28-32. PubMed ID: 22123931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
    Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
    Front Immunol; 2019; 10():1188. PubMed ID: 31191548
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy in a 27-year-old lady with systemic lupus erythematosus - rheumatoid arthritis overlap syndrome.
    Cheng CF; Su JJ; Chen YF; Lin YC; Huang YM; Li KJ
    J Formos Med Assoc; 2019 Nov; 118(11):1560-1565. PubMed ID: 31202498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive multifocal leukoencephalopathy following azathioprine and steroid treatment of pulmonary sarcoid disease].
    Franzen D; Mathys C; Vesper J; Malzkorn B; Bohlen H; Seitz RJ
    Dtsch Med Wochenschr; 2015 Aug; 140(17):1291-3. PubMed ID: 26306018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review.
    Hamaguchi M; Suzuki K; Fujita H; Uzuka T; Matsuda H; Shishido-Hara Y; Arai S; Nakamura T; Kikuchi S; Nakamichi K; Saijo M; Hirata K
    J Neurol; 2020 Mar; 267(3):731-738. PubMed ID: 31728711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progressive multifocal leukoencephalopathy in a patient with multiple myeloma].
    Willert CB; Engsig FN; Eskildsen HW; Andersen AB
    Ugeskr Laeger; 2014 Dec; 176(49):. PubMed ID: 25497861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus and autoimmune hepatitis.
    Gomathy S; Panigrahi B; Tirlangi PK; Wig N; Brijwal M; Sharma MC; Garg A; Tripathi M; Mohta S; Doddamani R; Vibha D; Singh RK; Yadav R; Sahu S; Suri V; Kaur K; Tripathi M; Rohatgi A; Elavarasi A
    Int J Rheum Dis; 2022 Jun; 25(6):705-713. PubMed ID: 35535671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus: Clues to early diagnosis.
    Law LY; Tan I; Prowse M; Sean Riminton D; Reddel SW
    J Clin Neurosci; 2019 Sep; 67():261-263. PubMed ID: 31278051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus.
    Kapoor T; Mahadeshwar P; Hui-Yuen J; Quinnies K; Tatonetti N; Gartshteyn Y; Guo C; Geraldino-Pardilla L; Askanase AD
    Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32513809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
    Tavazzi E; Ferrante P; Khalili K
    Clin Microbiol Infect; 2011 Dec; 17(12):1776-80. PubMed ID: 22082208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progressive multifocal leukoencephalopathy as a result of immunosuppressive therapy].
    Arbusow V; Strupp M; Samtleben W; Hatz H; Brückmann H; Brandt T
    Dtsch Med Wochenschr; 1999 May; 124(21):653-6. PubMed ID: 10382545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.